![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lack of pharmacokinetic drug-drug interaction
between bemnifosbuvir and ruzasvir in healthy participants
|
|
|
AASLD 2023 nov 10-14
https://www.aasld.org/the-liver-meeting
Xiao-Jian Zhou,1 Gaeteno Morelli,2 Maureen Montrond,1 Shannan Lynch,1 Keith Pietropaolo,1 Bruce Belanger,1 Arantxa Horga,1 Janet Hammond1
1Atea Pharmaceuticals, Boston, MA, USA; 2Altasciences Company, Montreal, Canada
![1113231](../images/111323/111323-9/1113231.gif)
![1113232](../images/111323/111323-9/1113232.gif)
![1113233](../images/111323/111323-9/1113233.gif)
![1113234](../images/111323/111323-9/1113234.gif)
![1113235](../images/111323/111323-9/1113235.gif)
![1113236](../images/111323/111323-9/1113236.gif)
![1113237](../images/111323/111323-9/1113237.gif)
![1113238](../images/111323/111323-9/1113238.gif)
![1113239](../images/111323/111323-9/1113239.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|